null

Mogamulizumab (Anti-CCR4) Biosimilar Antibody

SKU:
HDBS0079
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CCR4
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Mogamulizumab (Anti-CCR4) Biosimilar Antibody (HDBS0079)

The Mogamulizumab Biosimilar Anti-CCR4 Antibody offered by Assay Genie is a highly specific and reliable tool for research involving CCR4, a cell surface molecule implicated in immune regulation and associated with certain types of cancer. This antibody, generated through a biosimilar process, is validated for use in various applications, including flow cytometry and immunohistochemistry.CCR4, a chemokine receptor found on certain immune cells, plays a crucial role in immune cell trafficking and responses. Aberrant expression of CCR4 has been linked to various types of cancer, including T-cell lymphomas and certain solid tumors.

The Mogamulizumab biosimilar antibody binds specifically to the CCR4 protein, enabling accurate detection and analysis in a variety of research settings.Researchers in immunology and oncology will benefit from utilizing the Mogamulizumab Biosimilar Anti-CCR4 Antibody to further investigate the role of CCR4 in cancer development and progression. By understanding the mechanisms of CCR4 signaling, scientists can develop novel therapies targeting this pathway for the treatment of cancer and other immune-related disorders.